OOIR: Observatory of International Research

Papers

(The TQCC of Critical Reviews in Microbiology is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Candida albicans biofilms and polymicrobial interactions	97
Antimicrobial resistance: more than 70 years of war between humans and bacteria	91
A review of antibiotic resistance in Group B Streptococcus: the story so far	70
Bacterial survival strategies and responses under heavy metal stress: a comprehensive overview	69
Severe fever with thrombocytopenia syndrome virus: a highly lethal bunyavirus	66
Citric acid fromAspergillus niger: a comprehensive overview	65
Inhibition ofStreptococcus mutansbiofilm formation by strategies targeting the metabolism of exopolysaccharides	58
Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium	56
Recent advances in tackling microbial multidrug resistance with essential oils: combinatorial and nano-based strategies	53
Lung-brain axis	44
Advanced engineering of third-generation lysins and formulation strategies for clinical applications	44
Biological control as an alternative to synthetic fungicides for the management of grey and blue mould diseases of table grapes: a review	44
Community-wide changes reflecting bacterial interspecific interactions in multispecies biofilms	43
Global impact ofmcr-1-positiveEnterobacteriaceaebacteria on “one health”	42
Next-generation probiotics: a promising approach towards designing personalized medicine	42
Ways to control harmful biofilms: prevention, inhibition, and eradication	40
Lipopeptide families at the interface between pathogenic and beneficialPseudomonas-plant interactions	39
Water in bacterial biofilms: pores and channels, storage and transport functions	39
Exploiting solid lipid nanoparticles and nanostructured lipid carriers for drug delivery against cutaneous fungal infections	36
Akkermansia muciniphila plays critical roles in host health	33
Helicobacter pylori infection: from standard to alternative treatment strategies	33
Treatment strategies targeting persister cell formation in bacterial pathogens	31
Candida albicanstargets that potentially synergize with fluconazole	30
Microbial symbionts of insects as a source of new antimicrobials: a review	30
Multi-omics tools for studying microbial biofilms: current perspectives and future directions	29

Sneathia: an emerging pathogen in female reproductive disease and adverse perinatal outcomes	28
Extracellular polysaccharide biosynthesis in Cordyceps	26
The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential	26
Mixed biofilms of pathogenic Candida-bacteria: regulation mechanisms and treatment strategies	25
Polymicrobial interaction between Lactobacillus and Saccharomyces cerevisiae: coexistence-relevant mechanisms	25
Bdellovibrio bacteriovorus: a potential ‘living antibiotic’ to control bacterial pathogens	25
Listeria monocytogenes: review of pathogenesis and virulence determinants-targeted immunological assays	25
Ambient air pollution and respiratory bacterial infections, a troubling association: epidemiology, underlying mechanisms, and future challenges	23
Highlighting the use of micro and nanoparticles based-drug delivery systems for the treatment of Helicobacter pylori infections	23
Resistance to peptidoglycan-degrading enzymes	23
Bacterial infection and non-Hodgkin’s lymphoma	23
Is there evidence for bacterial transfer via the placenta and any role in the colonization of the infant gut? – a systematic review	23
Nanosystems against candidiasis: a review of studies performed over the last two decades	22
Colonization ofHelicobacter pyloriin the oral cavity – an endless controversy?	22
Diverse endophytic Streptomyces species with dynamic metabolites and their meritorious applications: a critical review	22
Bacterial adhesion to collagens: implications for biofilm formation and disease progression in the oral cavity	21
Making a case for using γδ T cells against SARS-CoV-2	21
Rotavirus-related systemic diseases: clinical manifestation, evidence and pathogenesis	21
Non-Melanoma Skin Cancer: news from microbiota research	21
Relevance of organ(s)-on-a-chip systems to the investigation of food-gut microbiota-host interactions	20
Role of the oral microbiome, metabolic pathways, and novel diagnostic tools in intra-oral halitosis: a comprehensive update	20
Applications of bacteriophages against intracellular bacteria	19
Antimicrobial coatings for environmental surfaces in hospitals: a potential new pillar for prevention strategies in hygiene	19
Mycobacterium tuberculosis extracellular vesicles: exploitation for vaccine technology and diagnostic methods	19
Metal-organic frameworks for diagnosis and therapy of infectious diseases	19
The role of microbial infection in the pathogenesis of Alzheimer’s disease and the opportunity for protection by anti-microbial peptides	19
Non-typeable Haemophilus influenzae chronic colonization in chronic obstructive pulmonary disease (COPD)	19
Guardian genes ensuring subsistence of oral Streptococcus mutans	18
Nisin resistance in Gram-positive bacteria and approaches to circumvent resistance for successful therapeutic use	18
The era of Cas12 and Cas13 CRISPR-based disease diagnosis	18
Burkholderia in the genomic era: from taxonomy to the discovery of new antimicrobial secondary metabolites	17
EnterohepaticHelicobacterspecies – clinical importance, host range, and zoonotic potential	17
The high osmolarity glycerol (HOG) pathway in fungi^†	17